Prosecution Insights
Last updated: August 18, 2026

Global Life Sciences Solutions USA LLC

12 pending office actions • 9 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days

Portfolio Summary

12
Total Pending OAs
5
Non-Final OAs
7
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (2)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (42%)
7
Medium (58%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only6 (50%)
Double-patenting + other1 (8%)
Multi-statute (no §101)5 (42%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

11
Life Sciences
92% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
8% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

120 h
Manual time on pending OAs
24 h
Time saved (low, 20%)
42 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BOWERS, NATHAN ANDREW 1 59.2% +32.1%
BORTOLI, JONATHAN 1 75.9% +42.1%
FISHER, BRITTANY I 1 84.3% +12.5%
KRCHA, MATTHEW D 1 65.0% +35.3%
HURST, JONATHAN M 1 53.3% +18.4%
SORKIN, DAVID L 1 67.3% +12.8%
VANN-OJUEKAIYE, KENDRA RAYCHELL 1 0.0% +0.0%
ESPERON, NATHAN GREGORY 1 40.7% +24.0%
ORLANDO, AMBER ROSE 1 63.9% +28.7%
WANG, RUIXUE 1 57.4% +22.1%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18038513 BIOPROCESSING SYSTEM AND METHODS FISHER, BRITTANY I

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18031664 BIOPROCESSING VESSEL HAVING INTEGRAL FLUID CONDUIT KRCHA, MATTHEW D 26d overdue
17108183 VIRAL VECTOR PURIFICATION APPARATUS AND METHOD WANG, RUIXUE 4d overdue
17998461 NOVEL HIGH-DENSITY MICROCARRIER RETENTION DEVICE FOR PERFUSION CULTURE AND METHOD OF USE THEREOF HURST, JONATHAN M 14d
18038803 APPARATUS AND METHOD FOR IN-LINE MONITORING OF A BIOPROCESS FLUID BORTOLI, JONATHAN
17615788 EXPRESSION OF PRODUCTS FROM NUCLEIC ACID CONCATEMERS VANN-OJUEKAIYE, KENDRA RAYCHELL
17061958 Connector for Flexible Tubing HANDY, DWAYNE K

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18031664 BIOPROCESSING VESSEL HAVING INTEGRAL FLUID CONDUIT KRCHA, MATTHEW D 26d overdue
17108183 VIRAL VECTOR PURIFICATION APPARATUS AND METHOD WANG, RUIXUE 4d overdue
17998461 NOVEL HIGH-DENSITY MICROCARRIER RETENTION DEVICE FOR PERFUSION CULTURE AND METHOD OF USE THEREOF HURST, JONATHAN M 14d
17292288 Bioreactor with Filter ESPERON, NATHAN GREGORY 33d
17905609 LINEAR PULSATING TYPE MAGNETIC MIXING SYSTEM AND AN ASSOCIATED METHOD OF OPERATION SORKIN, DAVID L 79d
18654163 APPARATUS FOR TRANSPORTING AND INSTALLING A BIOPROCESSING VESSEL BOWERS, NATHAN ANDREW
18038803 APPARATUS AND METHOD FOR IN-LINE MONITORING OF A BIOPROCESS FLUID BORTOLI, JONATHAN
18038513 BIOPROCESSING SYSTEM AND METHODS FISHER, BRITTANY I

Top Art Units

Art UnitApps
1796 2
1799 2
1678 1
1774 1
1682 1
1700 1
1672 1
1798 1
1631 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18654163 APPARATUS FOR TRANSPORTING AND INSTALLING A BIOPROCESSING VESSEL BOWERS, NATHAN ANDREW §103 Non-Final OA Pending May 03, 2024
18038803 APPARATUS AND METHOD FOR IN-LINE MONITORING OF A BIOPROCESS FLUID BORTOLI, JONATHAN 1678 §102§103§112 Non-Final OA Pending May 25, 2023
18038513 BIOPROCESSING SYSTEM AND METHODS FISHER, BRITTANY I 1796 §103 Non-Final OA Pending May 24, 2023
18031664 BIOPROCESSING VESSEL HAVING INTEGRAL FLUID CONDUIT KRCHA, MATTHEW D 1796 §102§103 Final Rejection 26d overdue Pending Apr 13, 2023
17998461 NOVEL HIGH-DENSITY MICROCARRIER RETENTION DEVICE FOR PERFUSION CULTURE AND METHOD OF USE THEREOF HURST, JONATHAN M 1799 §103§112 Final Rejection 14d Pending Nov 10, 2022
17905609 LINEAR PULSATING TYPE MAGNETIC MIXING SYSTEM AND AN ASSOCIATED METHOD OF OPERATION SORKIN, DAVID L 1774 §103 Non-Final OA 79d Pending Sep 02, 2022
17615788 EXPRESSION OF PRODUCTS FROM NUCLEIC ACID CONCATEMERS VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 §103 Final Rejection Pending Dec 01, 2021
17292288 Bioreactor with Filter ESPERON, NATHAN GREGORY 1799 §103DP Final Rejection 33d Pending May 07, 2021
17281711 A Bioreactor System ORLANDO, AMBER ROSE 1700 §103 Non-Final OA Pending Mar 31, 2021
17108183 VIRAL VECTOR PURIFICATION APPARATUS AND METHOD WANG, RUIXUE 1672 §103§112 Final Rejection 4d overdue Pending Dec 01, 2020
17061958 Connector for Flexible Tubing HANDY, DWAYNE K 1798 §102§103 Final Rejection Pending Oct 02, 2020
16968315 BIOPROCESSING METHODS FOR CELL THERAPY ZHU, JIANJIAN 1631 §103Other Final Rejection 27d Pending Aug 07, 2020

Managing Global Life Sciences Solutions USA LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month